PHARMACOVIGILANCE
Intelligence designed with safety at the center.
AI-assisted detection of potential safety information in digital conversations, with structured escalation to the company's pharmacovigilance circuit and human review at every step.
THE PROBLEM
Signals appear where nobody is looking.
Potential safety information doesn't only arrive through formal channels: it appears in digital conversations, patient messages, and everyday queries. Reviewing that volume manually doesn't scale, and a signal that goes unnoticed is a risk no pharmaceutical company wants to take.
HOW antonIA SOLVES IT
AI assists. Assessment remains human.
antonIA monitors the conversations its systems operate and flags potential adverse events for review. Every detected signal is captured in a structured format and routed to the pharmacovigilance contact designated by the company. Case assessment and management always remain in the hands of the pharmacovigilance team: the system assists detection and routing, with an audit trail of every step.
ARCHITECTURE
INCOMING MESSAGE
“I started feeling nauseous after taking the medication.”
POTENTIAL ADVERSE EVENT
CAPABILITIES
01Potential adverse event detection
Assisted classification of messages that could contain safety information.
02Structured capture
The available signal information is organized into a consistent format for review.
03Routing to the designated pharmacovigilance contact
Every signal reaches the contact point the company defined.
04Conversation monitoring
Continuous coverage of the conversational channels operated by the system.
05Reconciliation
Periodic verification that every flagged signal had its corresponding routing.
06Audit logs
Complete traceability: what was detected, when, and to whom it was routed.
07Human review
No signal is closed without assessment by the pharmacovigilance team.
AI LAYERS INVOLVED
- 06AI AGENTS
- 05ORCHESTRATION
- 04INTELLIGENCE
- 02COMPLIANCE
- 01SECURITY
FLOW VISUALIZATION
From interaction to the pharmacovigilance circuit
- Incoming interaction
- Potential safety signal
- AI detection
- Structured capture
- Human review
- Company pharmacovigilance circuit
antonIA assists in detecting and routing potential safety information. Case assessment and management always remain in the hands of the company's pharmacovigilance teams.
ENTERPRISE CONTROLS
Human-in-the-loop
Critical decisions remain connected to human review.
Audit logs
Every interaction and decision is recorded and queryable.
Structured escalation
Defined routing paths to the corresponding teams.
Data isolation
Separate environments per organization, with no information crossover.
Encryption
Data encrypted in transit and at rest.
Controlled knowledge
Answers from approved content, not from the model's open knowledge.
INTEGRATION POSSIBILITIES
The routing flow adapts to the pharmacovigilance circuit the company already has in place: designated contacts, capture formats, and routing times are configured according to its procedures.
- Company pharmacovigilance circuit
- Designated contacts
- Internal procedures
LET'S BUILD
Let's talk about safety with the seriousness it demands.
Assisted detection, structured escalation, and human review at every step.